Because expression of LPA3 and LPA3 signaling is highly dependent on female sex hormones (P4 and E2, respectively; Hama et al, 2006; Diao et al, 2015), this mechanism may operate not only in female reproduction but also in pathological diseases such as endometriosis and female reproductive cancers. Here, LPAR3 is linked to female reproductive organ cancer.